Multi-Dose IV Delivery Platform
The Opportunity: Reducing IV Medication Errors and Infection Risk | Intravenous medication administration is essential to modern healthcare, yet frequent…
Read More about Multi-Dose IV Delivery Platform
AI-Enabled Drug Discovery Platform
The Opportunity: Unlocking Previously “Undruggable” Diseases | Protein-protein interactions (PPIs) drive many of the biological pathways involved in cancer, autoimmune…
Read More about AI-Enabled Drug Discovery Platform
Respiratory Therapeutic for Chemical Exposure Emergencies
The Opportunity: Addressing a Critical Preparedness Gap | Chlorine is one of the most widely used industrial chemicals in the…
Read More about Respiratory Therapeutic for Chemical Exposure EmergenciesAll Technologies
Program: UWM Research Foundation
Multi-Dose IV Delivery Platform
Technology Sectors: Health & Bio, Medical Devices & Imaging
The Opportunity: Reducing IV Medication Errors and Infection Risk | Intravenous medication administration is essential to modern healthcare, yet frequent IV-line access creates opportunities for medication errors, contamination, and bloodstream infections. Current practice often requires multiple syringes, repeated line manipulations, and complex workflows that increase risk in emergency, critical care, and other high-pressure clinical settings.
Program: UWM Research Foundation
AI-Enabled Drug Discovery Platform
Technology Sectors: AI & Data Science, Health & Bio
The Opportunity: Unlocking Previously “Undruggable” Diseases | Protein-protein interactions (PPIs) drive many of the biological pathways involved in cancer, autoimmune disorders, and other serious diseases. Yet many PPIs remain difficult to target because of their complexity and dynamic behavior. As pharmaceutical companies increasingly invest in AI-enabled drug discovery, there is growing demand for platforms that
Program: UWM Research Foundation
Respiratory Therapeutic for Chemical Exposure Emergencies
Technology Sectors: Health & Bio
The Opportunity: Addressing a Critical Preparedness Gap | Chlorine is one of the most widely used industrial chemicals in the world and is a leading cause of toxic inhalation exposure. Accidental releases, transportation incidents, industrial accidents, and intentional misuse can result in serious lung injury, respiratory distress, and death. Despite the ongoing risk, there is
Program: Medical College of Wisconsin
Adaptive Dose‑Tracking Software for Radiation Therapy
Technology Sectors: Health & Bio, Medical Devices & Imaging
A truer picture of radiation dose for individualized cancer care As patients change during treatment, this innovation enables radiation dose assessment to change with them. By moving beyond static assumptions, it supports more accurate insight into how therapy affects tumors and healthy tissue—helping advance truly adaptive cancer treatment.
Program: Medical College of Wisconsin
Augmented Reality‑Guided MRI Procedures
Technology Sectors: Medical Devices & Imaging
Making MRI‑guided care clearer, faster, and safer By giving clinicians GPS‑like visual cues inside the MRI, this technology points toward a new standard for image‑guided care—where procedures are more precise, take less time, and place less burden on both patients and clinical teams.
Program: UWM Research Foundation
Low‑Cost Surface Alloying for Copper & Brass Castings
Technology Sectors: Industrial Technologies
Improving corrosion resistance and safety in critical metal components This technology enables foundries to produce safer, more durable copper and brass components by selectively upgrading surface performance. It improves corrosion resistance and reduces lead leaching using existing foundry processes—delivering higher‑quality products without changing bulk alloys or investing in new equipment.
Program: Medical College of Wisconsin
Next‑Generation Lyme Disease Vaccine
Technology Sectors: Health & Bio
Longer‑term protection for people and pets at risk As Lyme risk continues to expand, this innovation points toward a new generation of vaccines designed for durability—not short‑lived immunity. The approach aims to provide broader, longer‑term protection for both people and pets in regions where Lyme disease is becoming a persistent and growing threat.
Program: Versiti
Lipid‑Lowering Peptide for Cardiovascular Disease
Technology Sectors: Health & Bio
Addressing the heart‑disease risk that today’s drugs leave behind Even with medication, millions remain at risk for cardiovascular events. This innovation points toward a new class of therapies that address the full range of harmful blood lipoproteins—opening more complete and durable protection for patients underserved by today’s standard treatments.
Program: Versiti
Front-Line Antiviral Protection Platform
Technology Sectors: Health & Bio
Stopping Respiratory Infections Before They Take Hold This intranasal platform reimagines antiviral protection by acting at the body’s front line—where respiratory viruses begin infection. By anchoring protection directly to airway cells, it enables longer‑lasting defense and a flexible approach that can be rapidly adapted to new and emerging viral threats.
Program: Marquette University
Scalable Coaching Infrastructure for Behavior Change
Technology Sectors: AI & Data Science
Evidence-based coaching, built into software – so anyone can do it right, every time. Behavior change drives outcomes in healthcare and education, yet current tools do not scale, leaving clinicians and faculty without the time or structure to support individuals effectively. MyActionPlans.com embeds evidence-based coaching into existing workflows through a guided, web-based platform that enables